Dr. Daniel Blumberger is a Clinician Scientist in the Campbell Family Mental Health Research Institute at CAMH. He is the Medical Head and Co-Director of the Temerty Centre for Therapeutic Brain Intervention at CAMH. He is a subspecialist in geriatric psychiatry and also heads the Late-Life Mood Disorders Clinic. Dr. Blumberger is an Associate Professor in the Department of Psychiatry at the University of Toronto.
Areas of Research
Dr. Blumberger’s research focuses on the use of brain stimulation therapies for refractory psychiatric disorders. His main research focuses on clinical intervention trials of novel treatments, and understanding the neurophysiology of treatment-resistant depression across the lifespan. His research has been funded by the Canadian Institutes of Health Research, National Institute of Health, Brain Canada, Weston Brain Institute, Brain and Behavior Research Foundation, and Patient- Centered Outcomes Research Institute. He is the principal investigator or co-investigator on multiple clinical trials using different brain stimulation modalities including: magnetic seizure therapy (MST), repetitive transcranial magnetic stimulation (rTMS), deep rTMS and transcranial direct current stimulation (tDCS).
View Dr. Blumberger’s publications on PubMed.